Automated Real-time Feedback on CPR Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00539539 |
Recruitment Status :
Completed
First Posted : October 4, 2007
Results First Posted : June 25, 2012
Last Update Posted : June 25, 2012
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Heart Arrest | Other: Laerdal Q-CPR /technology | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 1586 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Controlled Study of the Clinical Effectiveness of Automated Real-Time Feedback on CPR Process Conducted at a Subset of ROC Sites |
Study Start Date : | February 2007 |
Actual Primary Completion Date : | June 2009 |
Actual Study Completion Date : | September 2009 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Feedback On
Automated real-time feedback on CPR Process activated
|
Other: Laerdal Q-CPR /technology
For the first three to six months, participating EMS agencies will have defibrillators with automated, real-time feedback inactivated. During this period, the baseline rate of ROSC (and secondary outcomes) will be collected. At the end of this baseline period, EMS agencies will be randomized to one of two interventions, with randomization stratified within site by agency, station, or device. All clusters will cross-over to the opposite feedback strategy at least once during the intervention phase. |
No Intervention: Feedback Off
For the first three to six months, participating EMS agencies will have defibrillators with automated, real-time feedback inactivated. During this period, the baseline rate of ROSC (and secondary outcomes) will be collected. At the end of this baseline period, EMS agencies will be randomized to one of two interventions, with randomization stratified within site by agency, station, or device. All clusters will cross-over to the opposite feedback strategy at least once during the intervention phase.
|
- Rate of ROSC During the Prehospital Resuscitation [ Time Frame: Prehospital resuscitation ]Return of spontaneous circulation (ROSC)
- Pulses Present at ED Arrival. [ Time Frame: Resuscitation ]
- Survival to Hospital Discharge [ Time Frame: Length of Hospitalization ]Survival to hospital discharge
- CPR Fraction [ Time Frame: Up to 10 minutes of CPR ]Percentage of time during CPR spend doing compressions.
- Compression Depth [ Time Frame: Up to 10 minutes of CPR ]Average compression depth (mm) during the first 10 minutes of CPR.
- Compression Rate [ Time Frame: Up to 10 minutes of CPR ]Average compression rate during the first 10 minutes of CPR.
- Percentage of Compressions With an Incomplete Release [ Time Frame: Up to 10 minutes of CPR ]Percentage of compressions with incomplete release during the first ten minutes of CPR.
- Ventilation Rate [ Time Frame: Up to 10 minutes of CPR ]Average ventilation rate (breaths/minute) during the first ten minutes of CPR.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- all individuals who experience cardiac arrest outside the hospital,
- are evaluated by organized EMS personnel and: a) receive attempts at external defibrillation (by lay responders or emergency personnel) or receive chest compressions by organized EMS personnel.
Exclusion Criteria:
- Use of a mechanical CPR device

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00539539
United States, Pennsylvania | |
University of Pittsburgh | |
Pittsburgh, Pennsylvania, United States, 15213 | |
United States, Washington | |
University of Washington | |
Seattle, Washington, United States, 98199 | |
Canada, Ontario | |
The Ottawa Hospital | |
Thunder Bay, Ontario, Canada, K1Y 4E9 |
Principal Investigator: | Susanne May, PhD | University of Washington | |
Study Director: | Judy Powell, BSN | University of Washington |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Susanne May, Professor, University of Washington |
ClinicalTrials.gov Identifier: | NCT00539539 |
Other Study ID Numbers: |
30707-A 5U01HL077863-08 ( U.S. NIH Grant/Contract ) 28765 ( Other Identifier: UW Human Subjects Division ) |
First Posted: | October 4, 2007 Key Record Dates |
Results First Posted: | June 25, 2012 |
Last Update Posted: | June 25, 2012 |
Last Verified: | May 2012 |
Heart Arrest Heart Diseases Cardiovascular Diseases |